Azithromycin to reduce childhood mortality in Sub-Saharan Africa
Submitted by susan on Thu, 2018-04-26 12:43
In this cluster-randomized trial, we assigned communities in Malawi, Niger, and Tanzania to four twice-yearly mass distributions of either oral azithromycin (approximately 20 mg per kilogram of body weight) or placebo. Children 1 to 59 months of age were identified in twice-yearly censuses and were offered participation in the trial. Vital status was determined at subsequent censuses. The primary outcome was aggregate all-cause mortality; country-specific rates were assessed in prespecified subgroup analyses.
Main Topic:
Mark Content Private(Internal):
Email Alert:
1583-1592
Publication Date:
26/04/2018